MedPath

Protocoled Quantitative Assessment of Aortic Regurgitation Using Videodensitometry in a Multicontinental Trial in Rotterdam, Montreal, Yamaguchi, Segeberg, Amsterdam.

Completed
Conditions
Aortic Valve Regurgitation
Aortic Valve Insufficiency
Interventions
Diagnostic Test: Standardized protocol for assessing aortic regurgitation using videodensitometry
Registration Number
NCT03644784
Lead Sponsor
Imperial College London
Brief Summary

The ASSESS-REGURGE is a multicenter, multicontinental registry on protocoled aortographic image acquisition after implantation of a transcatheter aortic valve. After the implementation of the acquisition protocol, each participating site will use the standardized approach for their center in order to identify if the images are considered analyzable via videodensitometry quantitative assessment of aortic regurgitation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
354
Inclusion Criteria
  • Eligible and undergoing TAVR procedure
Read More
Exclusion Criteria
  • Considered not eligible for TAVR procedure by the local Heart Team
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Yamaguchi University HospitalStandardized protocol for assessing aortic regurgitation using videodensitometry-
McGill University - MontrealStandardized protocol for assessing aortic regurgitation using videodensitometry-
Erasmus Medical CenterStandardized protocol for assessing aortic regurgitation using videodensitometry-
Segeberger Kliniken GruppeStandardized protocol for assessing aortic regurgitation using videodensitometry-
Academic Medical Center - AmsterdamStandardized protocol for assessing aortic regurgitation using videodensitometry-
Primary Outcome Measures
NameTimeMethod
Feasibility (percentage of the cases considered analyzable) of analysis of aortic regurgitation from aortograms using the videodensitometry technique1 year

Measurement of feasibility, i.e. the percentage of the number of cases, out of the entire sample size that are considered to be analyzable for quantitative aortic regurgitation assessment using videodensitometry after the implementation of the acquisition protocol. Since the analyzability of the aortic regurgitation from the aortograms depends in some acquisition factors, we will assess the feasibility of analysis after implantation of acquisition protocols.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

Segeberger Kliniken

🇩🇪

Bad Segeberg, Germany

Yamaguchi University

🇯🇵

Yamaguchi, Japan

McGill University

🇨🇦

Montréal, Canada

Erasmus Medical Center

🇳🇱

Rotterdam, Netherlands

Academic Medical Center

🇳🇱

Amsterdam, Netherlands

Imperial College

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath